However, we cannot rule out the possibility that the overexpression of the NF-κB pathway is associated with but does not directly promote MTX resistance in ALL cell lines; in this sense, the activation of NF-κB would be the byproduct of a transcriptional state characterized by MTX resistance but not the leading cause of it. The gene discussed is NFKB1; the disease is acute lymphoblastic leukemia.